What is Rymedi?
Rymedi is dedicated to empowering the healthcare industry through enhanced collaboration and value creation across disparate systems. Leveraging technology engineered to meet the most stringent global regulatory standards, Rymedi enables organizations within the healthcare ecosystem to more effectively capture, track, and share data. This capability is crucial for driving smarter, faster health impacts and ultimately improving patient outcomes. The company's focus on regulatory compliance positions it as a key player in a sector where data integrity and security are paramount.
How much funding has Rymedi raised?
Rymedi has raised a total of $9.2M across 2 funding rounds:
Debt
$150K
Series A
$9M
Debt (2020): $150K with participation from PPP
Series A (2023): $9M led by White Star Capital and Blockchange Ventures
Key Investors in Rymedi
White Star Capital
White Star Capital is a global multi-stage technology investment platform that partners with exceptional entrepreneurs to build ambitious international businesses. With a presence in major cities like New York, London, and Singapore, the firm focuses on venture investing at the Series A and B stages, as well as in digital assets and blockchain-enabled companies. Their team, equipped with extensive entrepreneurial and operational experience, supports founders in scaling their companies globally. White Star Capital aims to help reshape industries and drive innovation across transformative sectors.
Blockchange Ventures
We're a blockchain venture fund that backs extraordinary founders with visions as big and bold as the Blockchain itself. The company believes that the greatest business and investment outcomes from this generational technology shift will be the product of exceptional leadership and massive markets.
PPP
Public-Private Partnership
What's next for Rymedi?
The recent major strategic investment signals Rymedi's readiness for accelerated growth and market expansion. With a foundation built on robust technology and a clear understanding of healthcare's regulatory landscape, the company is poised to further solidify its position. Future developments will likely involve scaling its operations, enhancing its data collaboration platform, and potentially forging new strategic partnerships to broaden its reach and impact within the global healthcare sector. This funding will be instrumental in Rymedi's mission to transform healthcare data management and interoperability.
See full Rymedi company page
